81 related articles for article (PubMed ID: 24018494)
1. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients.
Gaba RC; Kallwitz ER; Parvinian A; Bui JT; Von Roenn NM; Berkes JL; Cotler SJ
Ann Hepatol; 2013; 12(5):766-73. PubMed ID: 24018494
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic Deprivation Does Not Impact Liver Transplantation Outcome for HCC: A Survival Analysis From a National Database.
Menahem B; Dejardin O; Alves A; Launay L; Lubrano J; Duvoux C; Laurent A; Launoy AG;
Transplantation; 2021 May; 105(5):1061-1068. PubMed ID: 32541559
[TBL] [Abstract][Full Text] [Related]
3. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis.
Arvind A; Seif El Dahan K; Malhotra R; Daher D; Rich NE; Patel MS; VanWagner LB; Lieber SR; Cotter TG; Louissaint J; Mufti AR; Kulik L; Pillai A; Parikh ND; Singal AG
Liver Transpl; 2024 Jun; 30(6):595-606. PubMed ID: 38466889
[TBL] [Abstract][Full Text] [Related]
4. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
Singal AG; Pillai A; Tiro J
PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
[TBL] [Abstract][Full Text] [Related]
5. Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma.
Hyder O; Dodson RM; Weiss M; Cosgrove DP; Herman JM; Geschwind JH; Kamel IR; Pawlik TM
J Gastrointest Surg; 2013 Oct; 17(10):1774-1783. PubMed ID: 23943387
[TBL] [Abstract][Full Text] [Related]
6. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.
Sonnenday CJ; Dimick JB; Schulick RD; Choti MA
J Gastrointest Surg; 2007 Dec; 11(12):1636-46; discussion 1646. PubMed ID: 17912593
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Access to Liver Transplant Referral and Evaluation among Patients with Hepatocellular Carcinoma in Georgia.
Ross-Driscoll K; Ayuk-Arrey AT; Lynch R; McCullough LE; Roccaro G; Nephew L; Hundley J; Rubin RA; Patzer R
Cancer Res Commun; 2024 Apr; 4(4):1111-1119. PubMed ID: 38517133
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.
Clavien PA; Lesurtel M; Bossuyt PM; Gores GJ; Langer B; Perrier A;
Lancet Oncol; 2012 Jan; 13(1):e11-22. PubMed ID: 22047762
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma.
Li J; Hansen BE; Peppelenbosch MP; De Man RA; Pan Q; Sprengers D
Oncotarget; 2017 Feb; 8(9):15193-15204. PubMed ID: 28122352
[TBL] [Abstract][Full Text] [Related]
10. Predicting survival time of Korean hepatocellular carcinoma patients using the Cox proportional hazards model: a retrospective study based on big data analysis.
Kwon Y; Kim JR; Park YM; Choi BK; Kim C; Young Kim H; Yoon M
Eur J Gastroenterol Hepatol; 2021 Jul; 33(7):1001-1008. PubMed ID: 33470702
[TBL] [Abstract][Full Text] [Related]
11. Transplantation for Hepatocellular Carcinoma.
Hill A; Olumba F; Chapman W
Surg Clin North Am; 2024 Feb; 104(1):103-111. PubMed ID: 37953029
[TBL] [Abstract][Full Text] [Related]
12. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.
Asemota J; Saleh M; Igbinovia O; Burns D
Cureus; 2020 Jul; 12(7):e9191. PubMed ID: 32818122
[TBL] [Abstract][Full Text] [Related]
13. Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.
Akbulut S; Garzali IU; Hargura AS; Aloun A; Yilmaz S
J Gastrointest Cancer; 2023 Jun; 54(2):408-419. PubMed ID: 35499649
[TBL] [Abstract][Full Text] [Related]
14. Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists.
Horvat N; de Oliveira AI; Clemente de Oliveira B; Araujo-Filho JAB; El Homsi M; Elsakka A; Bajwa R; Martins GLP; Elsayes KM; Menezes MR
Radiographics; 2022 Oct; 42(6):1670-1689. PubMed ID: 36190854
[TBL] [Abstract][Full Text] [Related]
15. Disparities in treatment and survival in early-stage hepatocellular carcinoma in California.
Gholami S; Kleber KT; Perry LM; Abidalhassan M; McFadden NR; Bateni SB; Maguire FB; Stewart SL; Morris C; Chen M; Gaskill CE; Merkow RP; Keegan TH
J Surg Oncol; 2023 Dec; 128(8):1302-1311. PubMed ID: 37610042
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a Hepatocellular Carcinoma Surveillance Program in a Community-Based Integrated Health System in Patients With Hepatitis C Cirrhosis.
Bui H; Kumar NG; Singal AG; Boparai J; Mukhtar NA; Tran D; Saxena V; Balasubramanian S
Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38334275
[TBL] [Abstract][Full Text] [Related]
17. Improved Survival in At-Risk Patients Undergoing Surveillance for Hepatocellular Carcinoma - A Nationwide Swedish Register-Based Study.
Thörn R; Hemmingsson O; Danielsson Borssén Å; Werner M; Karling P; Wixner J
J Hepatocell Carcinoma; 2023; 10():1573-1586. PubMed ID: 37753268
[TBL] [Abstract][Full Text] [Related]
18. Building the multidisciplinary team for management of patients with hepatocellular carcinoma.
Naugler WE; Alsina AE; Frenette CT; Rossaro L; Sellers MT
Clin Gastroenterol Hepatol; 2015 May; 13(5):827-35. PubMed ID: 24909910
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management.
Elderkin J; Al Hallak N; Azmi AS; Aoun H; Critchfield J; Tobon M; Beal EW
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958294
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Cancer Multidisciplinary Clinic is Associated with Improved Treatment and Elimination of Socioeconomic Disparities.
Hoehn RS; Zenati M; Rieser CJ; Stitt L; Winters S; Paniccia A; Zureikat AH
Ann Surg Oncol; 2024 Mar; 31(3):1906-1915. PubMed ID: 37989957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
